R&D News | pharmaphorum

News

Cancer Research UK earmarks £123m for Scottish R&D

Cancer Research UK (CRUK) has said it will award £123 million ($150 million) in funding over the next seven years to Scotland’s Beatson Institute, which will be renamed th

News

Smartphone app cuts racial disparity in post-birth care

Remote monitoring of blood pressure in women who have just given birth using a smartphone app can eliminate a disparity in care between Black and White patients, according

News

Roche inks pipeline deals with Orionis, PeptiDream

Roche has bolstered its R&D pipeline in oncology and neuroscience with a pair of partnerships with Orionis Biosciences and PeptiDream, parting with upfront cash of $87

News

Novo Nordisk Foundation pledges €127m for cell therapy plant

The Novo Nordisk Foundation is funding the creation of a cell therapy development and manufacturing facility in Denmark with one of the largest investments in the sector i

News

Changes ring at Oxford Bio as ABL takeover talks progress

UK contract development and manufacturer organisation (CDMO) Oxford Biomedica confirmed this morning it is in talks that could result in the acquisition of rival ABL Europ

News

DeepMind applies its AI expertise to genetic diseases

Google’s DeepMind unit has used its artificial intelligence expertise to catalogue millions of ‘missense’ mutations in human DNA that may be related to the development of

Cancer Research UK earmarks £123m for Scottish R&D

Smartphone app cuts racial disparity in post-birth care

Roche inks pipeline deals with Orionis, PeptiDream

Novo Nordisk Foundation pledges €127m for cell therapy plant

Changes ring at Oxford Bio as ABL takeover talks progress

DeepMind applies its AI expertise to genetic diseases

FDA grants three priority vouchers to psychedelics

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks